Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:53 AM
Ignite Modification Date:
2025-12-25 @ 4:53 AM
NCT ID:
NCT01485718
Eligibility Criteria:
Inclusion Criteria:
* Patients ≥18 years old
* Overweight (BMI ≥ 25 kg/m2)
Exclusion Criteria:
* Pregnant or nursing women
* Women of childbearing age will be excluded unless they are on some form of contraception
* Participation in any other formal or informal weight reduction program
1. Currently enrolled in another weight loss study
2. Currently enrolled in a weight loss program
3. Active attempt to lose weight with diet and/or exercise within the last month
4. Currently on one of the following medications known to cause weight loss:
* Alli/Xenical(orlistat)
* Adipex-P (phentermine)
* Bontril (phendimetrazine)
* Dexoxyn (methamphetamine)
* Didrex (benzphetamine)
* Tenuate (diethylpropion)
* Meridia (sibutramine)
* Byetta (exenatide) or Victoza (liraglutide)
* Stimulants
* Recently (within the last three months) started on any medication that may cause weight gain
* A diagnosis of heart failure
* Structural abnormalities of the esophagus or gut
* Previous GI surgery for weight reduction
* Inflammatory bowel or irritable bowel disease
* A life expectancy of \<6 months
* Allergy to glucomannan or any component of the placebo
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT01485718
Study Brief:
Protocol Section:
NCT01485718